Caplight Directory>Companies>Haermonics-preview>Haermonics


Haermonics

Haermonics

Private
EindhovenHealthcare & Life Scienceshttps://haermonics.com

Last Round

Series A

Aug 2, 2022

Total Funding Raised

$5.32M

Momentum Score

25 /100

Company Overview

Haermonics is a surgical devices company that has developed an innovative flush-therapy to prevent blood-related complications after open-heart surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

flush therapycardiac surgery devicepost-operative carepericardial flushingactive drainage systemopen-heart surgeryblood clot preventioncardiothoracic surgeryMedTechre-operation reductionmedical deviceclinical-stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Haermonics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Haermonics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AAug 2, 2022
DebtAug 9, 2021
GrantJun 1, 2015
GrantApr 1, 2015
View all Funding Rounds

Haermonics Investors

Notable investors and investment history

InvestorRounds
Brabantse Ontwikkelings MaatschappijSeries A
Invest-NLSeries A
Kansen voor WestGrant
View all Investors

Haermonics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Haermonics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Haermonics's valuation, stock price, and market status.

Firmographic Details

HeadquartersEindhoven
Employee Range16
Year Founded2015
Last FundingAug 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.